Skip to main content

ICPE 2022 Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Phyo T. Htoo photo

Phyo T. Htoo

Brigham and Women's Hospital/Harvard Medical School
Boston, Massachusetts, United States

Johnson & Johnson (Employment)

Presentation(s):

Effectiveness and Safety of Empagliflozin in Routine Care: Results from the Empagliflozin Comparative Effectiveness and Safety (EMPRISE) Study
Friday, August 26, 2022
6:15 PM – 6:20 PM CEST
Emulating Stratified Randomized Trials by Propensity Score Methods
Saturday, August 27, 2022
9:15 AM – 9:30 AM CEST
Cardiovascular Effectiveness of Empagliflozin vs. Glucagon-like peptide-1 Receptor Agonists or Liraglutide in the EMPRISE Study
Sunday, August 28, 2022
9:30 AM – 9:45 AM CEST
Using Iterative Causal Forest to Identify Heterogeneous Treatment Effects: Sodium-glucose Cotransporter-2 inhibitors versus Glucagon-like Peptide-1 Receptor Agonists on Hospitalization for Heart Failure
Sunday, August 28, 2022
9:45 AM – 10:00 AM CEST
Risk of Hypoglycemia with Sodium Glucose cotransporter-2 Inhibitors vs. Alternative Glucose Lowering Medications in Patients with and Without Baseline Use of Insulin or Sulfonylurea
Sunday, August 28, 2022
2:30 PM – 2:45 PM CEST